Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AEHR Aehr Test Systems	$17.42 -1.0%	$15.75	$6.27 ▼ $23.00	$521.06M	2.35	1.13 million shs	1.02 million shs
CTKB Cytek Biosciences	$4.01 -0.9%	$3.54	$2.37 ▼ $7.63	$509.53M	1.34	1.01 million shs	346,273 shs
KEQU Kewaunee Scientific	$55.84 -0.2%	$52.70	$30.33 ▼ $71.33	$164.56M	0.7	18,324 shs	2,436 shs
LAB Standard BioTools	$1.24 -2.8%	$1.26	$0.92 ▼ $2.32	$469.08M	1.32	1.75 million shs	955,139 shs

5G Stocks: The Path Forward is Profitable

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AEHR Aehr Test Systems	-9.28%	-9.56%	+16.72%	+107.67%	+23.01%
CTKB Cytek Biosciences	-0.49%	+0.25%	+29.07%	+62.90%	-26.94%
KEQU Kewaunee Scientific	-1.69%	-0.99%	+0.52%	+55.56%	+11.95%
LAB Standard BioTools	0.00%	-3.05%	+3.25%	+22.12%	-33.51%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AEHR Aehr Test Systems	1.9293 of 5 stars	0.0	3.0	0.0	1.9	2.5	1.9
CTKB Cytek Biosciences	3.1411 of 5 stars	3.1	5.0	0.0	1.8	4.2	0.0
KEQU Kewaunee Scientific	2.6015 of 5 stars	0.0	5.0	0.8	2.8	1.7	1.3
LAB Standard BioTools	2.3881 of 5 stars	2.0	3.0	0.0	3.1	4.2	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AEHR Aehr Test Systems	0.00	N/A	N/A	N/A
CTKB Cytek Biosciences	2.20	Hold	$5.60	39.83% Upside
KEQU Kewaunee Scientific	0.00	N/A	N/A	N/A
LAB Standard BioTools	2.00	Hold	$1.55	25.51% Upside

Current Analyst Ratings Breakdown

Latest KEQU, AEHR, CTKB, and LAB Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/13/2025	LAB Standard BioTools	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
8/13/2025	LAB Standard BioTools	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold	$1.55
7/17/2025	LAB Standard BioTools	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
5/28/2025	CTKB Cytek Biosciences	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$9.00 ➝ $7.00

(Data available from 8/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AEHR Aehr Test Systems	$58.97M	8.84	$0.10 per share	180.34	$4.13 per share	4.22
CTKB Cytek Biosciences	$196.04M	2.60	$0.03 per share	117.00	$2.97 per share	1.35
KEQU Kewaunee Scientific	$240.47M	0.68	$7.21 per share	7.75	$23.21 per share	2.41
LAB Standard BioTools	$172.27M	2.72	N/A	N/A	$1.12 per share	1.10

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AEHR Aehr Test Systems	-$3.91M	-$0.13	N/A	79.16	N/A	-6.63%	-0.15%	-0.13%	10/9/2025 (Estimated)
CTKB Cytek Biosciences	-$6.02M	-$0.05	N/A	∞	N/A	-3.27%	-1.66%	-1.30%	11/4/2025 (Estimated)
KEQU Kewaunee Scientific	$11.40M	$3.83	14.58	∞	N/A	4.74%	26.02%	9.87%	9/10/2025 (Estimated)
LAB Standard BioTools	-$138.88M	-$0.32	N/A	N/A	N/A	-69.08%	-20.23%	-15.32%	10/29/2025 (Estimated)

Latest KEQU, AEHR, CTKB, and LAB Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
7/8/2025	Q4 2025	AEHR Aehr Test Systems	-$0.02	-$0.01	+$0.01	-$0.10	$14.83 million	$14,100.00 billion
6/25/2025	Q4 2025	KEQU Kewaunee Scientific	N/A	$1.95	N/A	$1.63	N/A	$77.15 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AEHR Aehr Test Systems	N/A	N/A	N/A	N/A	N/A
CTKB Cytek Biosciences	N/A	N/A	N/A	N/A	N/A
KEQU Kewaunee Scientific	$0.76	1.36%	N/A	19.84%	N/A
LAB Standard BioTools	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AEHR Aehr Test Systems	N/A	5.68	2.99
CTKB Cytek Biosciences	N/A	5.22	4.55
KEQU Kewaunee Scientific	0.92	2.20	1.59
LAB Standard BioTools	N/A	5.16	5.37

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AEHR Aehr Test Systems	69.69%
CTKB Cytek Biosciences	69.46%
KEQU Kewaunee Scientific	32.69%
LAB Standard BioTools	53.74%

Insider Ownership

Company	Insider Ownership
AEHR Aehr Test Systems	6.20%
CTKB Cytek Biosciences	10.33%
KEQU Kewaunee Scientific	13.30%
LAB Standard BioTools	23.16%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AEHR Aehr Test Systems	90	29.92 million	28.06 million	Optionable
CTKB Cytek Biosciences	500	127.22 million	114.08 million	Optionable
KEQU Kewaunee Scientific	1,239	2.95 million	2.56 million	Not Optionable
LAB Standard BioTools	620	379.82 million	291.86 million	Optionable

KEQU, AEHR, CTKB, and LAB Headlines

Recent News About These Companies

Standard BioTools (NASDAQ:LAB) Raised to "Hold" at Wall Street Zen

August 18 at 3:47 AM | americanbankingnews.com

Standard BioTools Inc. (NASDAQ:LAB) Director Casdin Partners Master Fund, L Buys 75,000 Shares

August 17 at 10:59 PM | marketbeat.com

Insider Buying: Standard BioTools Inc. (NASDAQ:LAB) Director Acquires 133,220 Shares of Stock

August 17 at 10:59 PM | marketbeat.com

Casdin Partners Master Fund, L Purchases 150,000 Shares of Standard BioTools Inc. (NASDAQ:LAB) Stock

August 17 at 10:59 PM | marketbeat.com

Standard BioTools (NASDAQ:LAB) Upgraded by Wall Street Zen to "Hold" Rating

August 17 at 2:56 AM | marketbeat.com

Standard BioTools Inc. (NASDAQ:LAB) Director Purchases $98,250.00 in Stock

August 16, 2025 | insidertrades.com

Standard BioTools (NASDAQ:LAB) Downgraded to Hold Rating by TD Cowen

August 15, 2025 | marketbeat.com

Standard BioTools (NASDAQ:LAB) Downgraded by TD Cowen to Hold

August 15, 2025 | americanbankingnews.com

Standard BioTools downgraded to Hold from Buy at TD Cowen

August 13, 2025 | msn.com

Standard BioTools (NASDAQ:LAB) Issues Earnings Results

August 12, 2025 | marketbeat.com

Standard BioTools Delays Quarterly Report Filing

August 12, 2025 | tipranks.com

Standard BioTools (LAB) Reports Q2 Loss, Tops Revenue Estimates

August 11, 2025 | zacks.com

Standard BioTools Reports Second Quarter 2025 Financial Results

August 11, 2025 | globenewswire.com

What to Expect from Standard BioTools Inc (LAB) Q2 2025 Earnings

August 10, 2025 | finance.yahoo.com

Standard BioTools and Precision Health Research, Singapore (PRECISE-SG100K) Launch Proteomics Collaboration, Selecting SomaScan to Power Large-Scale Population Health Study

August 6, 2025 | globenewswire.com

GSA Capital Partners LLP Buys 478,922 Shares of Standard BioTools Inc. (NASDAQ:LAB)

August 4, 2025 | marketbeat.com

Standard BioTools (LAB) Projected to Post Quarterly Earnings on Monday

August 4, 2025 | marketbeat.com

Standard BioTools Approves Stock Awards for Executives

August 2, 2025 | msn.com

Pacific Capital Partners Ltd Buys Shares of 1,575,000 Standard BioTools Inc. (NASDAQ:LAB)

July 31, 2025 | marketbeat.com

Royce & Associates LP Increases Position in Standard BioTools Inc. (NASDAQ:LAB)

July 29, 2025 | marketbeat.com

Nikko Asset Management Americas Inc. Lowers Stock Holdings in Standard BioTools Inc. (NASDAQ:LAB)

July 27, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

KEQU, AEHR, CTKB, and LAB Company Descriptions

Aehr Test Systems NASDAQ:AEHR

$17.42 -0.18 (-0.99%)

Closing price 03:59 PM Eastern

Extended Trading

$17.34 -0.08 (-0.46%)

As of 04:12 PM Eastern

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The company also offers FOX-CP system, a low-cost single-wafer compact test solution for logic, memory, and photonic devices; FOX WaferPak Contactor, a full wafer contactor capable of testing wafers up to 300mm that enables integrated circuit manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. In addition, it provides FOX DiePak Carrier, a reusable temporary package that enables IC manufacturers to perform final test and burn-in of bare die and modules; and FOX DiePak Loader. The company was incorporated in 1977 and is headquartered in Fremont, California.

Cytek Biosciences NASDAQ:CTKB

$4.00 -0.04 (-0.87%)

Closing price 03:59 PM Eastern

Extended Trading

$4.00 0.00 (0.00%)

As of 04:04 PM Eastern

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Kewaunee Scientific NASDAQ:KEQU

$55.84 -0.10 (-0.18%)

Closing price 03:57 PM Eastern

Extended Trading

$57.73 +1.89 (+3.39%)

As of 04:05 PM Eastern

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

Standard BioTools NASDAQ:LAB

$1.24 -0.04 (-2.76%)

Closing price 03:59 PM Eastern

Extended Trading

$1.24 0.00 (0.00%)

As of 04:10 PM Eastern

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time